Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...

Introduction Cardiac Emergencies

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports Registry.

Heart rhythm O2·2025

Same author

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.

JAMA cardiology·2023

Same author

Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.

Circulation. Arrhythmia and electrophysiology·2021

Same author

Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.

European heart journal·2021

Same author

Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.

Progress in cardiovascular diseases·2020

Same author

Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.

European journal of preventive cardiology·2019

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Sudden cardiac arrest prevention pathways and tools.

Gregg C Fonarow¹, Nancy M Albert, David Cannom

¹Department of Medicine, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California 90095-1679, USA. gfonarow@mednet.ucla.edu

Critical Pathways in Cardiology

|June 4, 2009

Summary

Sudden cardiac arrest (SCA) prevention tools improve guideline adherence for high-risk patients. This program helps clinicians implement evidence-based care, aiming to enhance cardiovascular outcomes and patient management.

More Related Videos

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Utilizing the Modified T-Maze to Assess Functional Memory Outcomes After Cardiac Arrest

Published on: January 5, 2018

Area of Science:

Cardiology
Clinical Practice Guidelines
Preventive Medicine

Background:

Evidence-based guidelines exist for sudden cardiac arrest (SCA) risk management in heart failure and post-myocardial infarction patients.
Clinical practice often shows suboptimal adoption and inconsistent application of these cardiovascular treatment guidelines.
Treatment gaps persist due to a lack of accessible tools for identifying eligible patients and providing guideline reminders.

Purpose of the Study:

To introduce a comprehensive program of pathways and tools designed to facilitate optimal patient care for individuals at increased risk of SCA.
To support the recognition and implementation of evidence-based, guideline-recommended care across various healthcare settings.

Main Methods:

Development of a "SCA prevention pathways and tools program" for inpatient, outpatient, and transitional care.
The program focuses on identifying eligible patients and providing reminders for guideline-recommended interventions.
Implementation supports evidence-based care for patients with conditions like heart failure and left ventricular dysfunction post-myocardial infarction.

Main Results:

The program facilitates the adoption of best-care practices for SCA prevention.
It aims to assist healthcare providers in meaningfully improving cardiovascular care.
The initiative seeks to optimize clinical outcomes for at-risk patient populations.

Conclusions:

The SCA prevention pathways and tools program addresses the gap in guideline implementation.
It empowers clinicians to provide consistent, evidence-based care for SCA prevention.
The program is expected to lead to improved patient outcomes in cardiovascular medicine.